Premium
Communicating risk for thyroid FNA: The pursuit of a better metric
Author(s) -
Renshaw Andrew A.,
Krane Jeffrey F.
Publication year - 2020
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.22222
Subject(s) - medicine , gold standard (test) , malignancy , cytology , metric (unit) , thyroid , fine needle aspiration , thyroid cancer , medical physics , radiology , general surgery , pathology , biopsy , operations management , economics
Communicating the clinical significance of cytologic findings is a vital function of any cytology report. The simplicity and reproducibility of risk of malignancy (ROM), along with the wealth of accumulated data surrounding its use, mean that ROM remains the gold standard for measuring risk in thyroid fine‐needle aspiration specimens, one that is easily understood and has been found to be useful by cytologists, molecular pathologists, clinicians, and patients.